Madison Square Garden (NYSE:MSGS) Given New $305.00 Price Target at JPMorgan Chase & Co.

Madison Square Garden (NYSE:MSGS) had its target price boosted by JPMorgan Chase & Co. from $240.00 to $305.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

MSGS has been the topic of a number of other research reports. Citigroup raised their price objective on Madison Square Garden from $285.00 to $290.00 and gave the stock a “buy” rating in a research note on Tuesday, December 16th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Madison Square Garden in a research note on Monday, December 29th. Guggenheim reiterated a “buy” rating on shares of Madison Square Garden in a research note on Thursday. Zacks Research raised shares of Madison Square Garden from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Finally, Wolfe Research downgraded shares of Madison Square Garden from an “outperform” rating to a “hold” rating in a report on Monday, December 15th. Five investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Madison Square Garden currently has a consensus rating of “Hold” and a consensus price target of $272.17.

Madison Square Garden Price Performance

Shares of NYSE:MSGS opened at $279.21 on Friday. The company’s 50-day moving average price is $260.47 and its two-hundred day moving average price is $229.10. Madison Square Garden has a one year low of $173.26 and a one year high of $298.97. The stock has a market capitalization of $6.71 billion, a PE ratio of -404.65 and a beta of 0.61.

Madison Square Garden (NYSE:MSGS) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.66 by ($0.32). The firm had revenue of $403.42 million during the quarter, compared to the consensus estimate of $394.58 million. The firm’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.05 EPS. On average, analysts anticipate that Madison Square Garden will post 0.73 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Madison Square Garden

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Madison Square Garden during the second quarter worth about $288,000. Blume Capital Management Inc. acquired a new stake in Madison Square Garden in the 2nd quarter worth approximately $638,000. Y Intercept Hong Kong Ltd grew its position in Madison Square Garden by 775.0% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 16,888 shares of the company’s stock worth $3,529,000 after purchasing an additional 14,958 shares during the last quarter. Advisors Capital Management LLC increased its stake in Madison Square Garden by 12.2% during the 2nd quarter. Advisors Capital Management LLC now owns 11,861 shares of the company’s stock valued at $2,478,000 after purchasing an additional 1,291 shares in the last quarter. Finally, Vise Technologies Inc. purchased a new position in shares of Madison Square Garden in the second quarter worth $437,000. 68.94% of the stock is owned by institutional investors.

Key Headlines Impacting Madison Square Garden

Here are the key news stories impacting Madison Square Garden this week:

• Positive Sentiment: JPMorgan raised its price target on MSGS from $240 to $305 and assigned an “overweight” rating — signaling firm analyst conviction and potential upside from current levels (~9% uplift noted by the firm). This upgrade is a clear positive catalyst for buyer interest. JPMorgan Price Target Raise
• Positive Sentiment: Earnings call highlights and coverage emphasize strong revenue performance: revenue grew ~12.7% year-over-year to $403.4M and topped consensus — an encouraging sign for top-line momentum across MSGS’s sports and live-entertainment businesses. Positive commentary from management on revenue drove supportive market reaction. Q2 Call Highlights
• Neutral Sentiment: Full earnings call transcripts and analyst previews are now available for detail review — useful for parsing guidance, segment trends (MSG Sports vs. other businesses), and management comments but not new catalysts by themselves. Review the transcripts if you need detail on ticketing, media rights, or cost items. Earnings Call Transcript
• Negative Sentiment: EPS missed consensus materially: MSGS reported $0.34 EPS vs. $0.66 expected (despite revenue beat). The earnings shortfall is the primary near-term negative — it can pressure sentiment until analysts and investors see sustained margin recovery or clearer guidance. Earnings Miss Coverage

Madison Square Garden Company Profile

Madison Square Garden Sports Corp (NYSE: MSGS) is a leading sports and entertainment holding company focused on professional sports franchises and related media assets. The company owns and operates teams such as the NBA’s New York Knicks, the NHL’s New York Rangers and the WNBA’s New York Liberty. Through these flagship franchises, MSG Sports offers a range of products and services including ticketing, premium seating and sponsorship opportunities, targeting fans in the New York metropolitan area and beyond.

In addition to team operations, Madison Square Garden Sports Corp holds a majority stake in MSG Networks, a regional cable network that broadcasts live sporting events, news and original programming.